Summary & Overview

CPT 86337: Insulin Antibody Assay for Diabetes Evaluation

CPT code 86337 identifies an immunology laboratory assay that measures insulin antibodies in patient blood. The test is clinically important for distinguishing autoimmune type 1 diabetes from type 2 diabetes, evaluating suspected allergic reactions to insulin, and investigating poor glycemic control despite insulin therapy. Nationally, use of this test informs diagnostic clarity for diabetes subtypes and can influence ongoing treatment decisions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for ordering the test, typical sites of service, and which payers are considered in coverage and reimbursement discussions. The publication also provides benchmark metrics, common modifier usage, and guidance on documentation and billing workflow where available.

This summary aims to help laboratory directors, billing managers, and clinicians quickly understand the purpose and billing identity of CPT code 86337, the clinical scenarios that prompt ordering, and the payer landscape relevant to national billing and coverage considerations. Data not available in the input is noted where appropriate in detailed sections.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare86337CPTinsulin-antibodieslaboratory-immunologydiabetes-diagnosisvenipunctureoutpatient-labclinical-lab-billing

Billing Code Overview

CPT code 86337 is a laboratory immunology test that measures insulin antibodies in a patient’s blood. The test is ordered when clinicians suspect type 1 diabetes, an autoimmune cause of insulin deficiency, when a patient appears to have an allergic response to insulin, or when insulin therapy is ineffective at controlling blood glucose despite appropriate dosing.

Service type: Laboratory immunology test (antibody assay)

Typical site of service: Clinical laboratory or hospital outpatient laboratory, with specimen collection by venipuncture at the laboratory, physician office, or outpatient draw station.

Clinical & Coding Specifications

Clinical Context

A 14-year-old adolescent presents to a pediatric endocrinology clinic with recent onset of polyuria, polydipsia, weight loss, and mild diabetic ketoacidosis at presentation. The clinician orders an insulin antibody panel to help distinguish autoimmune type 1 diabetes from other causes of hyperglycemia and to evaluate for an immune-mediated reaction to exogenous insulin after ineffective glycemic control. A phlebotomy technician performs a venipuncture in the clinic or outpatient laboratory to collect a serum specimen. The specimen is sent to the laboratory; a clinical laboratory analyst performs the insulin antibody assay (e.g., radioimmunoassay or immunoassay). Results are reported in the electronic medical record; the ordering endocrinologist reviews antibody titers alongside C-peptide and glucose values to inform diagnosis and management decisions. Typical sites of service include outpatient clinic offices, hospital outpatient laboratories, and independent clinical reference laboratories.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the physician interpretation or professional portion when the laboratory provides technical component separately.
`TC`	Technical component	Use when reporting only the laboratory technical component (performing the assay, specimen processing).
`91`	Repeat clinical diagnostic laboratory test	Use when the same insulin antibody test is repeated on the same day for immediate confirmation or quality control.
`90`	Reference (outside) laboratory	Use when the specimen is sent to an outside reference lab and billing must indicate outside laboratory processing.
`59`	Distinct procedural service	Use when another separate and distinct laboratory or clinical service is provided the same day that is not typically billed together.
`52`	Reduced services	Use when the lab service was partially reduced or not completed as originally planned.
`53`	Discontinued procedure	Use when specimen collection or testing was started but discontinued for documented reasons.
`22`	Increased procedural services	Use when the laboratory documents substantially greater work or complexity for testing beyond typical processing.
`76`	Repeat procedure by same provider	Use when the same provider repeats specimen collection or the assay on another occasion (note: `76` not in provided list; excluded)
`90`	Reference (outside) laboratory	Use when testing is performed by an outside lab (duplicate entry avoided)

Taxonomy Code	Specialty	Notes
207RC0000X	Endocrinology, Diabetes & Metabolism	Common ordering specialty for insulin antibody testing.
207L00000X	Pathology & Laboratory Medicine	Laboratories and pathologists overseeing serologic testing and interpretation.
363A00000X	Phlebotomy	Providers or services performing venipuncture specimen collection.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Venipuncture is the typical specimen collection method prior to performing the insulin antibody assay.
`81025`	Urinalysis, non-automated, with microscopy	Urinalysis may be ordered concurrently to assess glucosuria or ketonuria in suspected new-onset diabetes.
`83036`	Hemoglobin; glycosylated (A1C)	Commonly performed to assess chronic glycemic control in patients evaluated for diabetes.
`82947`	Glucose; quantitative, blood (except reagent strip)	Concurrent glucose measurement to correlate antibody results with glycemic status.
`84443`	Thyroid stimulating hormone (TSH)	Autoimmune thyroid disease frequently coexists with type 1 diabetes; TSH may be ordered as part of autoimmune evaluation.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E10.9`	Type 1 diabetes mellitus without complications	Insulin antibody testing helps support autoimmune etiology in new-onset or unclear diabetes.
`R73.9`	Hyperglycemia, unspecified	When hyperglycemia is present and etiology is unclear, antibody testing aids diagnostic clarification.
`T88.1XXA`	Other complications following immunization, initial encounter	Included where immune responses to insulin therapy or preparations are suspected (use clinically as appropriate).
`T85.79XA`	Other complications of internal prosthetic devices, implants and grafts, initial encounter	Placeholder for device-related reactions when insulin delivery devices are implicated (use clinically as appropriate).
`Z79.4`	Long term (current) use of insulin	Testing may be ordered when patients on long-term insulin have loss of efficacy or suspected antibody-mediated resistance.